Resultado da Busca
Chor D, Faerstein E. Um enfoque epidemiológico da promoção da saúde: as idéias de Geoffrey Rose. Cad Saude Publica. 2000; 16(1):241-4. in both the societal and individual dimensions. It relates to the restoration of environmental and social conditions and health-friendly ways of living, presenting relatively few problems regarding the scientific basis for its recommendation.
Estrategias Da Medicina Preventiva. Capa comum – 20 novembro 2009. Edição Português por Geoffrey Rose (Autor) 5,0 1 classificação. Ver todos os formatos e edições. Livro fora de catálogo. Relatar um problema com este produto. ISBN-10. 8536321210.
1 de jun. de 2001 · Abstract. Rose G (Department of Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK). Sick individuals and sick populations. International Journal of Epidemiology 1985; 14: 32–38.
1 de jan. de 2000 · In this paper, we discuss some of the ideas developed by Geoffrey Rose, which are seldom explicitly expressed in the contemporary debate on health promotion. The following notions are emphasized ...
O paradoxo da prevenção foi descrito formalmente pela primeira vez em 1981 [1] pelo epidemiologista Geoffrey Rose. O paradoxo da prevenção descreve a situação aparentemente contraditória em que a maioria dos casos de uma doença provém de uma população com risco baixo (ou moderado) dessa doença, e apenas uma minoria de casos provém da população de alto risco.
4 de dez. de 2008 · Since its publication in 1992, Geoffrey Rose's The Strategy of Preventive Medicine has been required reading for those interested in population health, social epidemiology, or preventive medicine. Given the explosion of research on the social determinants of health that has taken place in the ensuing years, interested readers are likely to welcome a new edition of this classic text.
15 de out. de 2012 · Geoffrey Rose, MD. 1926 — 1993. Geoffrey Rose received his education at Oxford University and his medical training at St. Mary’s Hospital. Professor Rose led cardiovascular disease (CVD) epidemiology from his posts at the London School of Hygiene and Tropical Medicine and St. Mary’s Hospital between the early 1960s and 1991 when he retired.
